Quarterly Update

Occlutech Q1 2024

Occlutech Q1 2024 – A Strong Start to the Year

Q1 2024

Occlutech Q2 2024

Occlutech Q2 2024 – Strong Growth, Efficiency, and Strategic Execution

Q2 2024

Occlutech Q4 2023

Occlutech Q4 2023 – Key approval in the US, solid progress in clinical study and continued strong growth

Q4 2023

Occlutech Q3 2023

Occlutech Q3 2023 - Achieving continued growth across geographies and sales channels with a positive outlook for year end

Q3 2023

Occlutech Q1 2023

Occlutech Q1 2023 – Growth momentum with increased sales and marketing activities

Q1 2023

Occlutech Q2 2023

Occlutech Q2 2023 – Continued strong revenue growth

Q2 2023

Occlutech Q3 2022

Occlutech Q3 2022 – Revenue growth, increased market activity and operational preparations

Q3 2022

Occlutech Year-end report 2022

Occlutech Year-end report 2022 – Significant uptick in sales growth as transformation processes are reaching an end

Q4 2022

Occlutech Q2 2022

Positive revenue growth and important milestones achieved in the strategic US market

Q2 2022

Occlutech Q1 2022

To meet the high interest for Occlutech and its development the company will issue a quarterly release from Q1 2022, which will include revenue development and comments from the CEO.

Q1 2022